Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,886 | -65,890 | -107,468 | -250,008 | -97,403 |
| Depreciation Amortization | 18,011 | 18,417 | 18,969 | 40,385 | 10,124 |
| Accounts receivable | -7,404 | -1,852 | -495 | -4,238 | -964 |
| Accounts payable and accrued liabilities | -1,384 | -581 | 970 | N/A | N/A |
| Other Working Capital | -6,770 | -18,745 | 9,834 | 8,037 | 3,621 |
| Other Operating Activity | 21,291 | -7,550 | 3,215 | 155,050 | 48,880 |
| Operating Cash Flow | $-78,142 | $-76,201 | $-74,975 | $-50,774 | $-35,742 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -164,835 | 53,161 | 39,335 | -242,374 |
| PPE Investments | -27,194 | -18,654 | -16,288 | -34,321 | -53,850 |
| Net Acquisitions | 22,450 | N/A | 3,443 | -82,051 | N/A |
| Purchase Of Investment | -534,717 | -14,492 | N/A | N/A | N/A |
| Sale Of Investment | 397,807 | 192,401 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -2,292 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,524 |
| Investing Cash Flow | $-141,654 | $-5,580 | $40,316 | $-77,037 | $-299,748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,399 | 118,463 | 1,146 | 17,653 | 461,487 |
| Debt Repayment | -8,347 | -19,717 | -2,863 | -1,089 | -50 |
| Common Stock Issued | 211,362 | 2,554 | 441 | 6,049 | 17,322 |
| Other Financing Activity | 0 | 0 | 40,000 | 0 | -40,687 |
| Financing Cash Flow | $207,414 | $101,300 | $38,724 | $22,613 | $438,072 |
| Beginning Cash Position | 44,446 | 24,927 | 30,814 | 136,012 | 33,430 |
| End Cash Position | 32,064 | 44,446 | 34,879 | 30,814 | 136,012 |
| Net Cash Flow | $-12,382 | $19,519 | $4,065 | $-105,198 | $102,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,142 | -76,201 | -74,975 | -50,774 | -35,742 |
| Capital Expenditure | -27,194 | -18,746 | -16,327 | -34,321 | -53,850 |
| Free Cash Flow | -105,336 | -94,947 | -91,302 | -85,095 | -89,592 |